Tesamorelin 5 mg

稳定化的生长激素释放激素类似物，文献关注其对内脏脂肪组织及 IGF-1 轴活性的影响（研究模型）。

Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.

Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

作用机制

文献关注其选择性结合 GHRH 受体并具有延长半衰期。研究与受试人群内脏脂肪指标降低及 IGF-1 升高相关。